O	O	0	8	Dopamine	Dopamine	B-NP	NN	O	2	SUB	O
O	O	9	19	stimulates	stimulate	B-VP	VBZ	O	0	ROOT	O
O	O	20	30	expression	expression	B-NP	NN	O	2	OBJ	O
O	O	31	33	of	of	B-PP	IN	O	3	NMOD	O
O	O	34	37	the	the	B-NP	DT	O	9	NMOD	O
O	O	38	43	human	human	I-NP	JJ	O	9	NMOD	O
O	O	44	60	immunodeficiency	immunodeficiency	I-NP	NN	O	9	NMOD	O
O	O	61	66	virus	virus	I-NP	NN	O	9	NMOD	O
O	O	67	71	type	type	I-NP	NN	O	4	PMOD	O
O	O	72	73	1	1	I-NP	CD	O	9	NMOD	O
O	O	74	77	via	via	B-PP	IN	O	2	VMOD	O
T8	B-Entity	78	80	NF	NF	B-NP	NN	B-protein	14	NMOD	B-protein
T8	I-Entity	80	81	-	-	I-NP	HYPH	I-protein	14	NMOD	I-protein
T8	I-Entity	81	87	kappaB	kappaB	I-NP	NN	I-protein	11	PMOD	I-protein
O	O	88	90	in	in	B-PP	IN	O	2	VMOD	O
O	O	91	96	cells	cell	B-NP	NNS	O	15	PMOD	O
O	O	97	99	of	of	B-PP	IN	O	16	NMOD	O
O	O	100	103	the	the	B-NP	DT	O	20	NMOD	O
O	O	104	110	immune	immune	I-NP	JJ	O	20	NMOD	O
O	O	111	117	system	system	I-NP	NN	O	17	PMOD	O
O	O	117	118	.	.	O	.	O	2	P	O

O	O	120	126	Recent	Recent	B-NP	JJ	O	2	NMOD	O
O	O	127	134	studies	study	I-NP	NNS	O	3	SUB	O
O	O	135	139	have	have	B-VP	VBP	O	0	ROOT	O
O	O	140	148	reported	report	I-VP	VBN	O	3	VC	O
O	O	149	153	that	that	B-SBAR	IN	O	4	VMOD	O
O	O	154	165	lymphocytes	lymphocyte	B-NP	NNS	B-cell_type	7	SUB	B-cell_type
O	O	166	173	produce	produce	B-VP	VBP	O	5	SBAR	O
O	O	173	174	,	,	O	,	O	7	P	O
O	O	175	184	transport	transport	B-VP	VBP	O	7	VMOD	O
O	O	185	188	and	and	I-VP	CC	O	7	VMOD	O
O	O	189	193	bind	bind	I-VP	VBP	O	7	VMOD	O
O	O	194	202	dopamine	dopamine	B-NP	NN	O	7	VMOD	O
O	O	203	210	present	present	B-ADJP	JJ	O	12	NMOD	O
O	O	211	213	in	in	B-PP	IN	O	13	AMOD	O
O	O	214	220	plasma	plasma	B-NP	NN	O	14	PMOD	O
O	O	220	221	.	.	O	.	O	3	P	O

O	O	222	229	However	However	B-ADVP	RB	O	19	VMOD	O
O	O	229	230	,	,	O	,	O	19	P	O
O	O	231	234	the	the	B-NP	DT	O	4	NMOD	O
O	O	235	241	action	action	I-NP	NN	O	19	SUB	O
O	O	242	244	of	of	B-PP	IN	O	4	NMOD	O
O	O	245	253	dopamine	dopamine	B-NP	NN	O	5	PMOD	O
O	O	254	256	on	on	B-PP	IN	O	4	NMOD	O
T9	B-Entity	257	260	HIV	HIV	B-NP	NN	B-DNA	11	NMOD	B-DNA
T9	I-Entity	260	261	-	-	B-NP	HYPH	I-DNA	11	NMOD	I-DNA
T9	I-Entity	261	262	1	1	I-NP	CD	I-DNA	11	NMOD	I-DNA
T9	I-Entity	263	267	gene	gene	I-NP	NN	I-DNA	12	NMOD	I-DNA
O	O	268	278	expression	expression	I-NP	NN	O	7	PMOD	O
O	O	279	281	in	in	B-PP	IN	O	12	NMOD	O
O	O	282	287	cells	cell	B-NP	NNS	O	13	PMOD	O
O	O	288	290	of	of	B-PP	IN	O	14	NMOD	O
O	O	291	294	the	the	B-NP	DT	O	18	NMOD	O
O	O	295	301	immune	immune	I-NP	JJ	O	18	NMOD	O
O	O	302	308	system	system	I-NP	NN	O	15	PMOD	O
O	O	309	312	has	have	B-VP	VBZ	O	0	ROOT	O
O	O	313	316	not	not	I-VP	RB	O	19	VMOD	O
O	O	317	320	yet	yet	I-VP	RB	O	19	VMOD	O
O	O	321	325	been	be	I-VP	VBN	O	19	VC	O
O	O	326	334	examined	examine	I-VP	VBN	O	22	VC	O
O	O	334	335	.	.	O	.	O	19	P	O

O	O	336	340	Here	Here	B-ADVP	RB	O	4	VMOD	O
O	O	340	341	,	,	O	,	O	4	P	O
O	O	342	344	we	we	B-NP	PRP	O	4	SUB	O
O	O	345	349	have	have	B-VP	VBP	O	0	ROOT	O
O	O	350	362	investigated	investigate	I-VP	VBN	O	4	VC	O
O	O	363	366	the	the	B-NP	DT	O	7	NMOD	O
O	O	367	377	regulation	regulation	I-NP	NN	O	5	OBJ	O
O	O	378	380	of	of	B-PP	IN	O	7	NMOD	O
O	O	381	384	HIV	HIV	B-NP	NN	O	12	NMOD	O
O	O	384	385	-	-	B-NP	HYPH	O	12	NMOD	O
O	O	385	386	1	1	I-NP	CD	O	12	NMOD	O
O	O	387	397	expression	expression	I-NP	NN	O	8	PMOD	O
O	O	398	400	by	by	B-PP	IN	O	7	NMOD	O
O	O	401	409	dopamine	dopamine	B-NP	NN	O	13	PMOD	O
O	O	410	412	in	in	B-PP	IN	O	14	NMOD	O
O	O	413	419	Jurkat	Jurkat	B-NP	NN	B-cell_line	18	NMOD	B-cell_line
O	O	420	421	T	T	I-NP	NN	I-cell_line	18	NMOD	I-cell_line
O	O	422	427	cells	cell	I-NP	NNS	I-cell_line	15	PMOD	I-cell_line
O	O	428	431	and	and	B-PP	CC	O	13	PMOD	O
O	O	432	434	in	in	B-PP	IN	O	13	PMOD	O
O	O	435	442	primary	primary	B-NP	JJ	B-cell_type	24	NMOD	B-cell_type
O	O	443	448	blood	blood	I-NP	NN	I-cell_type	24	NMOD	I-cell_type
O	O	449	460	mononuclear	mononuclear	I-NP	JJ	I-cell_type	24	NMOD	I-cell_type
O	O	461	466	cells	cell	I-NP	NNS	I-cell_type	20	PMOD	I-cell_type
O	O	467	468	(	(	O	(	O	27	DEP	O
O	O	468	472	PBMC	PBMC	B-NP	NN	B-cell_type	27	DEP	B-cell_type
O	O	472	473	)	)	O	)	O	24	NMOD	O
O	O	473	474	.	.	O	.	O	4	P	O

O	O	475	478	HIV	HIV	B-NP	NN	O	4	NMOD	O
O	O	478	479	-	-	B-NP	HYPH	O	4	NMOD	O
O	O	479	480	1	1	I-NP	CD	O	4	NMOD	O
O	O	481	492	replication	replication	I-NP	NN	O	5	SUB	O
O	O	493	496	was	be	B-VP	VBD	O	0	ROOT	O
O	O	497	506	increased	increase	I-VP	VBN	O	5	VC	O
O	O	507	509	by	by	B-PP	IN	O	6	VMOD	O
O	O	510	518	dopamine	dopamine	B-NP	NN	O	7	PMOD	O
O	O	518	519	,	,	O	,	O	8	P	O
O	O	520	525	which	which	B-NP	WDT	O	8	NMOD	O
O	O	526	536	correlated	correlate	B-VP	VBD	O	10	SBAR	O
O	O	537	541	with	with	B-PP	IN	O	11	VMOD	O
O	O	542	545	the	the	B-NP	DT	O	15	NMOD	O
O	O	546	555	increased	increase	I-NP	VBN	O	15	NMOD	O
O	O	556	562	levels	level	I-NP	NNS	O	12	PMOD	O
O	O	563	565	of	of	B-PP	IN	O	15	NMOD	O
O	O	566	569	HIV	HIV	B-NP	NN	O	20	NMOD	O
O	O	569	570	-	-	B-NP	HYPH	O	20	NMOD	O
O	O	570	571	1	1	I-NP	CD	O	20	NMOD	O
O	O	572	587	transactivation	transactivation	I-NP	NN	O	16	PMOD	O
O	O	587	588	.	.	O	.	O	5	P	O

O	O	589	592	Our	Our	B-NP	PRP$	O	4	NMOD	O
O	O	593	602	transient	transient	I-NP	JJ	O	4	NMOD	O
O	O	603	613	expression	expression	I-NP	NN	O	4	NMOD	O
O	O	614	618	data	datum	I-NP	NNS	O	5	SUB	O
O	O	619	627	revealed	reveal	B-VP	VBD	O	0	ROOT	O
O	O	628	632	that	that	B-SBAR	IN	O	5	VMOD	O
O	O	633	641	dopamine	dopamine	B-NP	NN	O	8	SUB	O
O	O	642	652	stimulated	stimulate	B-VP	VBD	O	6	SBAR	O
O	O	653	666	transcription	transcription	B-NP	NN	O	8	OBJ	O
O	O	667	674	through	through	B-PP	IN	O	8	VMOD	O
O	O	675	678	the	the	B-NP	DT	O	15	NMOD	O
T10,T11	B-Entity,B-Entity	679	681	NF	NF	I-NP	NN	B-DNA	15	NMOD	B-DNA
T10,T11	I-Entity,I-Entity	681	682	-	-	O	HYPH	I-DNA	15	NMOD	I-DNA
T10,T11	I-Entity,I-Entity	682	688	kappaB	kappaB	B-NP	NN	I-DNA	15	NMOD	I-DNA
T10	I-Entity	689	696	element	element	I-NP	NN	I-DNA	10	PMOD	I-DNA
O	O	697	704	present	present	B-ADJP	JJ	O	15	NMOD	O
O	O	705	707	in	in	B-PP	IN	O	16	AMOD	O
O	O	708	711	the	the	B-NP	DT	O	21	NMOD	O
T12	B-Entity	712	716	long	long	I-NP	JJ	B-DNA	21	NMOD	B-DNA
T12	I-Entity	717	725	terminal	terminal	I-NP	JJ	I-DNA	21	NMOD	I-DNA
T12	I-Entity	726	732	repeat	repeat	I-NP	NN	I-DNA	17	PMOD	I-DNA
O	O	732	733	.	.	O	.	O	5	P	O

O	O	734	737	The	The	B-NP	DT	O	2	NMOD	O
O	O	738	748	importance	importance	I-NP	NN	O	8	SUB	O
O	O	749	751	of	of	B-PP	IN	O	2	NMOD	O
T13,T14	B-Entity,B-Entity	752	754	NF	NF	B-NP	NN	O	7	NMOD	O
T13,T14	I-Entity,I-Entity	754	755	-	-	B-NP	HYPH	O	7	NMOD	O
T13,T14	I-Entity,I-Entity	755	761	kappaB	kappaB	I-NP	NN	B-DNA	7	NMOD	B-DNA
T13	I-Entity	762	767	sites	site	I-NP	NNS	I-DNA	3	PMOD	I-DNA
O	O	768	771	was	be	B-VP	VBD	O	0	ROOT	O
O	O	772	781	confirmed	confirm	I-VP	VBN	O	8	VC	O
O	O	782	784	by	by	B-PP	IN	O	9	VMOD	O
O	O	785	790	using	use	B-VP	VBG	O	10	PMOD	O
O	O	791	798	vectors	vector	B-NP	NNS	O	11	OBJ	O
O	O	799	809	containing	contain	B-VP	VBG	O	12	NMOD	O
O	O	810	814	wild	wild	B-NP	JJ	B-DNA	20	NMOD	B-DNA
O	O	814	815	-	-	I-NP	HYPH	I-DNA	20	NMOD	I-DNA
O	O	815	819	type	type	I-NP	NN	I-DNA	20	NMOD	I-DNA
O	O	820	822	or	or	I-NP	CC	I-DNA	20	NMOD	I-DNA
O	O	823	829	mutant	mutant	I-NP	JJ	I-DNA	20	NMOD	I-DNA
T15	B-Entity	830	836	kappaB	kappaB	I-NP	NN	I-DNA	20	NMOD	I-DNA
T15	I-Entity	837	842	sites	site	I-NP	NNS	I-DNA	13	OBJ	I-DNA
O	O	843	845	in	in	B-PP	IN	O	20	NMOD	O
O	O	846	847	a	a	B-NP	DT	O	24	NMOD	O
T16	B-Entity	848	860	heterologous	heterologous	I-NP	JJ	B-DNA	24	NMOD	B-DNA
T16	I-Entity	861	869	promoter	promoter	I-NP	NN	I-DNA	21	PMOD	I-DNA
O	O	869	870	.	.	O	.	O	8	P	O

O	O	871	881	Consistent	Consistent	B-ADJP	JJ	O	18	VMOD	O
O	O	882	886	with	with	B-PP	IN	O	1	AMOD	O
O	O	887	890	the	the	B-NP	DT	O	4	NMOD	O
O	O	891	895	role	role	I-NP	NN	O	2	PMOD	O
O	O	896	898	of	of	B-PP	IN	O	4	NMOD	O
T17	B-Entity	899	901	NF	NF	B-NP	NN	B-protein	8	NMOD	B-protein
T17	I-Entity	901	902	-	-	B-NP	HYPH	I-protein	8	NMOD	I-protein
T17	I-Entity	902	908	kappaB	kappaB	I-NP	NN	I-protein	5	PMOD	I-protein
O	O	909	911	in	in	B-PP	IN	O	4	NMOD	O
O	O	912	921	mediating	mediate	B-VP	VBG	O	9	PMOD	O
O	O	922	930	dopamine	dopamine	B-NP	NN	O	12	NMOD	O
O	O	931	945	responsiveness	responsiveness	I-NP	NN	O	10	OBJ	O
O	O	945	946	,	,	O	,	O	18	P	O
O	O	947	950	the	the	B-NP	DT	O	17	NMOD	O
O	O	951	961	proteasome	proteasome	I-NP	NN	B-protein	17	NMOD	B-protein
O	O	962	971	inhibitor	inhibitor	I-NP	NN	O	17	NMOD	O
O	O	972	977	MG132	MG132	I-NP	NN	O	18	SUB	O
O	O	978	987	abolished	abolish	B-VP	VBD	O	0	ROOT	O
O	O	988	996	dopamine	dopamine	B-NP	NN	O	23	NMOD	O
O	O	996	997	-	-	B-NP	HYPH	O	23	NMOD	O
O	O	997	1004	induced	induce	I-NP	VBN	O	23	NMOD	O
O	O	1005	1020	transcriptional	transcriptional	I-NP	JJ	O	23	NMOD	O
O	O	1021	1031	activation	activation	I-NP	NN	O	18	OBJ	O
O	O	1031	1032	.	.	O	.	O	18	P	O

O	O	1033	1035	We	We	B-NP	PRP	O	3	SUB	O
O	O	1036	1043	further	further	B-ADVP	RB	O	3	VMOD	O
O	O	1044	1052	explored	explore	B-VP	VBD	O	0	ROOT	O
O	O	1053	1056	the	the	B-NP	DT	O	5	NMOD	O
O	O	1057	1063	effect	effect	I-NP	NN	O	3	OBJ	O
O	O	1064	1066	of	of	B-PP	IN	O	5	NMOD	O
O	O	1067	1075	dopamine	dopamine	B-NP	NN	O	6	PMOD	O
O	O	1076	1078	in	in	B-PP	IN	O	5	NMOD	O
O	O	1079	1082	the	the	I-PP	DT	O	10	NMOD	O
O	O	1083	1091	presence	presence	I-PP	NN	O	8	PMOD	O
O	O	1092	1094	of	of	I-PP	IN	O	10	NMOD	O
O	O	1095	1102	phorbol	phorbol	B-NP	NN	O	13	NMOD	O
O	O	1103	1109	esters	ester	I-NP	NNS	O	17	NMOD	O
O	O	1110	1112	or	or	O	CC	O	17	NMOD	O
T1	B-Protein	1113	1118	tumor	tumor	B-NP	NN	B-protein	17	NMOD	B-protein
T1	I-Protein	1119	1127	necrosis	necrosis	I-NP	NN	I-protein	17	NMOD	I-protein
T1	I-Protein	1128	1134	factor	factor	I-NP	NN	I-protein	19	NMOD	I-protein
T1	I-Protein	1134	1135	-	-	O	HYPH	O	19	P	O
T1	I-Protein	1135	1140	alpha	alpha	B-NP	SYM	O	11	PMOD	O
O	O	1141	1142	(	(	O	(	O	24	DEP	O
T2	B-Protein	1142	1145	TNF	TNF	B-NP	NN	B-protein	23	NMOD	B-protein
T2	I-Protein	1145	1146	-	-	O	HYPH	O	23	P	O
T2	I-Protein	1146	1151	alpha	alpha	B-NP	SYM	O	24	DEP	O
O	O	1151	1152	)	)	O	)	O	19	NMOD	O
O	O	1153	1158	known	know	B-VP	VBN	O	19	NMOD	O
O	O	1159	1161	to	to	I-VP	TO	O	27	VMOD	O
O	O	1162	1170	activate	activate	I-VP	VB	O	25	VMOD	O
T18	B-Entity	1171	1173	NF	NF	B-NP	NN	B-protein	30	NMOD	B-protein
T18	I-Entity	1173	1174	-	-	B-NP	HYPH	I-protein	30	NMOD	I-protein
T18	I-Entity	1174	1180	kappaB	kappaB	I-NP	NN	I-protein	27	OBJ	I-protein
O	O	1180	1181	.	.	O	.	O	3	P	O

O	O	1182	1185	The	The	B-NP	DT	O	2	NMOD	O
O	O	1186	1197	combination	combination	I-NP	NN	O	0	ROOT	O
O	O	1198	1200	of	of	B-PP	IN	O	2	NMOD	O
O	O	1201	1209	dopamine	dopamine	B-NP	NN	O	8	NMOD	O
O	O	1210	1213	and	and	I-NP	CC	O	8	NMOD	O
T3	B-Protein	1214	1217	TNF	TNF	I-NP	NN	B-protein	8	NMOD	B-protein
T3	I-Protein	1217	1218	-	-	O	HYPH	O	8	P	O
T3	I-Protein	1218	1223	alpha	alpha	B-NP	SYM	O	3	PMOD	O
O	O	1224	1227	led	lead	B-VP	VBD	O	8	NMOD	O
O	O	1228	1230	to	to	B-PP	TO	O	9	VMOD	O
O	O	1231	1232	a	a	B-NP	DT	O	12	NMOD	O
O	O	1233	1244	stimulation	stimulation	I-NP	NN	O	10	PMOD	O
O	O	1245	1247	of	of	B-PP	IN	O	12	NMOD	O
O	O	1248	1251	HIV	HIV	B-NP	NN	O	19	NMOD	O
O	O	1251	1252	-	-	B-NP	HYPH	O	19	NMOD	O
O	O	1252	1253	1	1	I-NP	CD	O	19	NMOD	O
O	O	1254	1267	transcription	transcription	I-NP	NN	O	19	NMOD	O
O	O	1268	1271	and	and	I-NP	CC	O	19	NMOD	O
O	O	1272	1283	replication	replication	I-NP	NN	O	13	PMOD	O
O	O	1283	1284	.	.	O	.	O	2	P	O

O	O	1285	1292	However	However	B-ADVP	RB	O	12	VMOD	O
O	O	1292	1293	,	,	O	,	O	12	P	O
O	O	1294	1296	in	in	B-PP	IN	O	12	VMOD	O
O	O	1297	1305	contrast	contrast	B-NP	NN	O	3	PMOD	O
O	O	1306	1310	with	with	B-PP	IN	O	4	NMOD	O
T4	B-Protein	1311	1314	TNF	TNF	B-NP	NN	B-protein	11	NMOD	B-protein
T4	I-Protein	1314	1315	-	-	O	HYPH	O	11	NMOD	O
T4	I-Protein	1315	1320	alpha	alpha	B-NP	SYM	O	11	NMOD	O
O	O	1320	1321	,	,	O	,	O	11	P	O
O	O	1322	1330	dopamine	dopamine	B-NP	NN	O	11	NMOD	O
O	O	1331	1340	treatment	treatment	I-NP	NN	O	5	PMOD	O
O	O	1341	1344	did	do	B-VP	VBD	O	0	ROOT	O
O	O	1345	1348	not	not	I-VP	RB	O	12	VMOD	O
O	O	1349	1355	affect	affect	I-VP	VB	O	12	VC	O
T19	B-Entity	1356	1358	NF	NF	B-NP	NN	B-protein	17	NMOD	B-protein
T19	I-Entity	1358	1359	-	-	I-NP	HYPH	I-protein	17	NMOD	I-protein
T19	I-Entity	1359	1365	kappaB	kappaB	I-NP	NN	I-protein	20	NMOD	I-protein
T20	I-Entity	1366	1369	DNA	DNA	I-NP	NN	O	20	NMOD	O
O	O	1370	1377	binding	binding	I-NP	NN	O	20	NMOD	O
O	O	1378	1386	activity	activity	I-NP	NN	O	23	NMOD	O
O	O	1387	1390	nor	nor	O	CC	O	23	NMOD	O
O	O	1391	1394	the	the	B-NP	DT	O	23	NMOD	O
O	O	1395	1409	concentrations	concentration	I-NP	NNS	O	14	OBJ	O
O	O	1410	1412	of	of	B-PP	IN	O	23	NMOD	O
T5	B-Protein	1413	1416	p50	p50	B-NP	NN	B-protein	29	NMOD	B-protein
O	O	1416	1417	,	,	O	,	O	29	P	O
T6	B-Protein	1418	1421	p65	p65	B-NP	NN	B-protein	29	NMOD	B-protein
O	O	1422	1425	and	and	I-NP	CC	O	29	NMOD	O
T7	B-Protein	1426	1433	IkappaB	IkappaB	I-NP	NN	B-protein	32	NMOD	B-protein
T7	I-Protein	1433	1434	-	-	B-NP	HYPH	O	32	NMOD	O
T7	I-Protein	1434	1439	alpha	alpha	I-NP	SYM	O	32	NMOD	O
O	O	1440	1448	proteins	protein	I-NP	NNS	O	24	PMOD	O
O	O	1448	1449	,	,	O	,	O	32	P	O
O	O	1450	1455	which	which	B-NP	WDT	O	32	NMOD	O
O	O	1456	1464	suggests	suggest	B-VP	VBZ	O	34	SBAR	O
O	O	1465	1466	a	a	B-NP	DT	O	42	NMOD	O
O	O	1467	1475	distinct	distinct	I-NP	JJ	O	42	NMOD	O
T21	B-Entity	1476	1478	NF	NF	I-NP	NN	B-protein	42	NMOD	B-protein
T21	I-Entity	1478	1479	-	-	B-NP	HYPH	I-protein	42	NMOD	I-protein
T21	I-Entity	1479	1485	kappaB	kappaB	I-NP	NN	I-protein	42	NMOD	I-protein
O	O	1486	1496	activation	activation	I-NP	NN	O	42	NMOD	O
O	O	1497	1506	mechanism	mechanism	I-NP	NN	O	35	OBJ	O
O	O	1506	1507	.	.	O	.	O	12	P	O

O	O	1508	1513	These	These	B-NP	DT	O	2	NMOD	O
O	O	1514	1521	results	result	I-NP	NNS	O	3	SUB	O
O	O	1522	1528	reveal	reveal	B-VP	VBP	O	0	ROOT	O
O	O	1529	1530	a	a	B-NP	DT	O	6	NMOD	O
O	O	1531	1534	new	new	I-NP	JJ	O	6	NMOD	O
O	O	1535	1539	link	link	I-NP	NN	O	3	OBJ	O
O	O	1540	1547	between	between	B-PP	IN	O	6	NMOD	O
O	O	1548	1551	the	the	B-NP	DT	O	10	NMOD	O
O	O	1552	1560	dopamine	dopamine	I-NP	NN	O	10	NMOD	O
O	O	1561	1567	system	system	I-NP	NN	O	16	NMOD	O
O	O	1567	1568	,	,	O	,	O	16	P	O
O	O	1569	1577	cytokine	cytokine	B-NP	NN	B-protein	14	NMOD	B-protein
O	O	1578	1587	signaling	signaling	I-NP	NN	O	14	NMOD	O
O	O	1588	1595	pathway	pathway	I-NP	NN	O	16	NMOD	O
O	O	1596	1599	and	and	O	CC	O	16	NMOD	O
O	O	1600	1610	regulation	regulation	B-NP	NN	O	7	PMOD	O
O	O	1611	1613	of	of	B-PP	IN	O	16	NMOD	O
O	O	1614	1618	gene	gene	B-NP	NN	O	19	NMOD	O
O	O	1619	1629	expression	expression	I-NP	NN	O	17	PMOD	O
O	O	1630	1633	via	via	B-PP	IN	O	16	NMOD	O
O	O	1634	1637	the	the	B-NP	DT	O	22	NMOD	O
O	O	1638	1649	involvement	involvement	I-NP	NN	O	20	PMOD	O
O	O	1650	1652	of	of	B-PP	IN	O	22	NMOD	O
T22	B-Entity	1653	1655	NF	NF	B-NP	NN	B-protein	26	NMOD	B-protein
T22	I-Entity	1655	1656	-	-	B-NP	HYPH	I-protein	26	NMOD	I-protein
T22	I-Entity	1656	1662	kappaB	kappaB	I-NP	NN	I-protein	23	PMOD	I-protein
O	O	1663	1665	in	in	B-PP	IN	O	22	NMOD	O
O	O	1666	1667	T	T	B-NP	NN	B-cell_type	29	NMOD	B-cell_type
O	O	1668	1673	cells	cell	I-NP	NNS	I-cell_type	31	NMOD	I-cell_type
O	O	1674	1677	and	and	O	CC	O	31	NMOD	O
O	O	1678	1682	PBMC	PBMC	B-NP	NN	B-cell_type	27	PMOD	B-cell_type
O	O	1682	1683	.	.	O	.	O	3	P	O
